BP000508-PKA-348: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Beta Protein
Source: E. coli-derived.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000510-PKA-238: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Gamma Protein
Source: E. coli-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000510-PKA-262: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Gamma Protein, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000512-PKA-254: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Theta Protein
Source: E. coli-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000093-CYT-149: Recombinant Human 4-1BB Ligand
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by the dose-dependent stimulation of IL-8 production by human PBMC. The ED50 for this effect is 5-10ug/ml corresponding to a Specific Activity of 100,000-200,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000093-CYT-649: Recombinant Human 4-1BB Ligand, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000094-CYT-137: Recombinant Human 4-1BB Receptor, His Tag
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP000094-CYT-463: Recombinant Human 4-1BB Receptor
Source: E. coli-derived.
The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inhibition using 1 for both 4-1BB ligand and 4-1BB receptor.
Purity > 98%, by SDS-PAGE and RP-HPLC.APIM050002: A-1331852
CAS No.: 1430844-80-6
Molecular Formula: C38H38N6O3S.
Molecular Weight: 658.8 (or refer to the Certificate of Analysis, batch-specific).
Purity: >99.5% by HPLC at 214 and 254 nm.
QC: HPLC-MS, NMR, and Quantitative Elemental Analysis.
Solubility: DMSO.C007P: Abatacept Biosimilar
Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
Specificity/Sensitivity: The abatacept biosimilar protein specifically binds to the human CTLA-4.
Applications: Functional assays, and those assays for studying biological pathways affected by abatacept.